相关实验视频
Updated: Jan 11, 2026

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
19.0K
精神分裂症的补充药物治疗:它能改善长期的结果吗? 一个系统的审查
Alexandros Smyrnis1, Giorgos Smyrnis1, Nikolaos Smyrnis1
12nd Department of Psychiatry, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 124 62 Athens, Greece.
Journal of clinical medicine
|November 13, 2025
概括
对精神分裂症 (SCZ) 的长期补充药物显示在残留症状和复发预防方面具有不一致的益处. 需要进一步的研究来评估这些治疗方法的长期疗效和安全性.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学 是一个学科.
- 临床研究 临床研究
背景情况:
- 精神分裂症 (SCZ) 常常呈现残留症状和复发尽管抗精神病治疗.
- 补充药物通常用于SCZ的临床实践,但长期证据有限.
- 现有的证据主要来自短期试验,需要对长期结果进行审查.
研究的目的:
- 系统地审查精神分裂症谱系障碍中辅助药物的长期临床结果和复发预防效果.
- 评估临床实践中使用的各种类别的附加剂的疗效.
- 评估SCZ中长期治疗策略的证据质量.
主要方法:
- 按照PRISMA指南进行系统审查,搜索PubMed和Scopus (2000-2025年).
- 包括在SCZ频谱障碍中使用添加剂长达24周的试验,比较使用和不使用添加剂的抗精神病治疗.
- 主要结局:长期症状变化;次要结局:复发. 使用Cochrane RoB 2工具评估偏差风险.
主要成果:
- 分析了22项研究,将添加剂分为经常使用的 (抗抑郁药,情绪稳定剂) 和不太常用的 (认知增强剂,抗生素,抗氧化剂/抗炎药).
- 在所有药物类别中,临床疗效结果是混合的,没有任何药物显示出强大的长期益处.
- 报告指出,消耗率很高 (平均为29.5%),但对方法的担忧其他方面是微不足道的. 复发数据是有限的.
结论:
- 目前关于在精神分裂症中补充药物治疗的长期疗效的证据不一致.
- 没有特定的附加药物类别在症状管理或复发预防方面始终表现出可靠的长期益处.
- 这些发现突显了人们对长期多药学的担忧,并强调了未来需要研究更长的随访和现实的治疗模式的需要.
相关概念视频
Drug Therapy
236
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
236
Psychosis: Goals of Pharmacotherapy
453
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
453
Psychosis and Antipsychotic Drugs: Overview
788
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
788
Antipsychotic Drugs: Therapeutic Uses and Side Effects
722
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
722
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Antipsychotic Drugs: Typical and Atypical Agents
722
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
722

